Business Information
The group's principal activity is to develop and market novel therapeutic and predictive medicine products. The group operates in two segments, research and predictive medicine. The research segment focuses on the discovery of genes and proteins related to major common diseases, the discovery of their related biological pathways and the development of therapeutic products for the treatment and prevention of major diseases. The predictive medicine segment provides testing to determine predisposition to common diseases. The group has made discoveries in the fields of cancer, viral diseases such as aids and acute thrombosis. It has alliances with 12 major multinational companies including abbott laboratories, bayer corporation, e.i. Du pont de nemours and company (dupont), eli lilly and company, hitachi ltd, hoffmann-laroche inc, novartis corporation, oracle corporation, pharmacia corporation, schering ag, schering-plough corporation and torrey mesa research institute.
|
|
Name |
Title
|
Email
|
| John Henderson | Chmn. | N/A | | Jay Moyes | CFO | N/A | | Mark Skolnick | Dir., Chief Scientific Officer | N/A | | Jerry Lanchbury | Exec. VP - Research | N/A | | Richard Marsh | Exec. VP, General Counsel, Sec. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 114,279 | (38,189) | | 2005 | 82,406 | (39,978) | | 2004 | 56,648 | (40,620)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
